EMAIL DETAILS

Neil,

I'd love to hire a veteran, if you know anyone that could help in the
management of our company that is a veteran I'd welcome the opportunity to
speak with that person.

Best,

Michael

On Tue, Apr 3, 2012 at 11:13 PM, Neil Callahan (Rosemont Seneca) <
ncallahan@rosemontseneca.com> wrote:

> Good luck in Toronto.
>
> How close are you to being a Veteran owned business? Do you have any
> Veterans on staff? Plans to fire Veterans?
>
>
> Neil Callahan
> Rosemont Seneca Partners
> 401 Greenwich Street, Suite 300
> New York, New York 10013
> 917-945-9516 (m)
> 866-749-8879 (f)
>
> Confidentiality Warning: This e-mail contains information intended only for
> the use of the individual or entity named above. If the reader of this
> e-mail is not the intended recipient or the employee or agent responsible
> for delivering it to the intended recipient, any dissemination, publication
> or copying of this e-mail is strictly prohibited. The sender does not
> accept
> any responsibility for any loss, disruption or damage to your data or
> computer system that may occur while using data contained in, or
> transmitted
> with, this e-mail.If you have received this e-mail in error, please
> immediately notify us by return e-mail. Thank you
>
>
> -----Original Message-----
> From: Michael Solimene [mailto:msolimene@ovationbiotech.com]
> Sent: Tuesday, April 03, 2012 6:46 AM
> To: Eric Schwerin
> Cc: Hunter Biden; Neil Callahan; rwalker@rosemontseneca.com; Laird Bunch
> Subject: Re: In DC this week
>
> Eric,
> Absolutely we can have a call next week mon or tues or the following week
> of
> the 16th anytime. I am in Toronto next Wed - Fri negotiating a JV with the
> largest biodiesel company in Canada who wants to build their next refinery
> in partnership with us in the USA (they sell 100% of their Canadian made
> fuel in the US).
>
> Please feel free to suggest a time that suits you best. I look
> forward to sharing our progress with you.
>
> Best regards,
>
> Michael
>
> Michael Solimene
> Chief Executive Officer
> Ovation Biotech, Inc
> 919-526-0269
>
> Please note my new email address msolimene@ovationbiotech.com
>
>
> On Apr 2, 2012, at 9:21 PM, Eric Schwerin <eschwerin@rosemontseneca.com>
> wrote:
>
> > Michael-
> >
> > That all sounds exciting and I am glad it wasn't Laird that you named
> > as your COO.
> >
> > Hunter is just getting back from a week away for Spring Break with his
> > family and we are consequently trying to squeeze two weeks into one
> > this week. Can we catch up by phone in the next week or two after we
> > get through this week? Rob is out of the country this week as well
> > and I'd like him to be on the call as well.
> >
> > Let us know what your schedule is like next week or the week after next.
> >
> > Best,
> >
> > Eric
> >
> > Sent from my iPad
> >
> > On Apr 2, 2012, at 9:07 AM, Michael Solimene
> > <msolimene@ovationbiotech.com> wrote:
> >
> >> Hunter,
> >> My apologies I did not give you more advanced notice - but I am in DC
> >> this week at the Advanced Biofuels Leadership Conference. Since we
> >> last met, I have made some strong progress in commercial partnerships
> >> and would welcome the opportunity to share with you, Eric, Rob or
> >> Neil if anyone has time this week.
> >>
> >> We are negotiating with two publicly listed fuel companies for JV
> >> agreements focused on our patented technology. Additionally I
> >> brought on a new COO, a very skillful guy i have known for 15+ years,
> >> who is focused on the enzyme side of our business. We believe the
> >> enzyme business has a margin potential far in excess of the fuels
> >> business an a very quick time to market for high value products.
> >>
> >> If you and/or the team have some time, I will gladly come over to
> >> Georgetown for a quick update.
> >>
> >> Also- completed the company rebranding - we are now Ovation Biotech,
> Inc.
> >>
> >> Best regards,
> >>
> >> Michael
> >>
> >> Michael Solimene
> >> Chief Executive Officer
> >> Ovation Biotech, Inc
> >> 919-526-0269
> >>
> >> Please note my new email address msolimene@ovationbiotech.com
>